Search for obtaining the highest net clinical benefit in pulmonary embolism patients: A new improvement considering the safety of thrombolysis
Thromb Res
.
2022 Oct:218:5-7.
doi: 10.1016/j.thromres.2022.07.016.
Epub 2022 Aug 8.
Author
Koracevic Goran
1
Affiliation
1
Department for Cardiovascular Diseases, University Clinical Center Nis, Medical Faculty, University of Nis, Serbia. Electronic address: gkoracevic@yahoo.com.
PMID:
35961066
DOI:
10.1016/j.thromres.2022.07.016
No abstract available
Publication types
Editorial
Comment
MeSH terms
Fibrinolytic Agents / adverse effects
Humans
Pulmonary Embolism* / drug therapy
Thrombolytic Therapy / adverse effects
Treatment Outcome
Substances
Fibrinolytic Agents